The COSENTIXX brand, founded in 2012 (Switzerland), from 2951 sister brands and 17477 competing brands. COSENTIXX is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. COSENTIXX belongs to the Drug Manufacturers business sector.